TransAct Technologies Reports Preliminary Third Quarter 2021 Financial Results

2021 Third Quarter Net Sales of $10.6 Million

FST Recurring Revenue of $2.0 Million, up 28% on a Year-Over-Year Basis

FST Paid Terminals Up 129% from September 30, 2020

TransAct Technologies Incorporated (Nasdaq: TACT) (“TransAct” or the “Company”), a global leader in software-driven technology and printing solutions for high-growth markets, today reported preliminary operating results for the quarter ended September 30, 2021.

“Our results mark the highest quarterly net sales since the fourth quarter of 2019, due to sustained momentum in BOHA! and our key Food Service Technology (“FST”) business, and a fantastic rebound in our domestic casino and gaming markets. We posted another quarter of over $2 million in recurring FST revenue, including gains in our high margin software and label recurring revenues, even in the face of a then-surging Delta variant. We also saw some solid BOHA! terminal additions, and we ended the quarter at 8,749 paid terminals in the market, representing over 3,000 added during the first nine months of 2021. Even though we are only in the early stages of our BOHA! growth story, we are already seeing the power of our recurring revenue base beginning to drive consistent results. We are also experiencing continued strong interest in our BOHA! solution to help with the labor shortages faced by our FST customers,” said Bart C. Shuldman, Chairman and CEO of TransAct. “In addition, we are really pleased with the encouraging trends in the casino and gaming market, with sales up over 100% year-over-year to $4 million for the third quarter of 2021. The domestic rebound is leading the way, courtesy of the continued reinvestment in the casino floor, as the American gamer clearly has been very eager to return to business as usual.”

Third Quarter 2021 Financial Highlights

  • Net Sales: Net sales for the third quarter of 2021 were $10.6 million, up 46% compared to $7.3 million for the third quarter of 2020.
  • FST Recurring Revenue: FST recurring revenue for the third quarter of 2021 was $2.0 million, up 28% compared to $1.6 million for the third quarter of 2020.
  • Gross Profit: Gross profit for the third quarter of 2021 was $4.3 million, resulting in gross margin of 40.6%, compared to gross profit of $3.3 million for the third quarter of 2020, which resulted in a 45.9% gross margin.
  • Operating loss: Operating loss for the third quarter of 2021 was $(1.6) million, compared to operating loss of $(1.5) million for the third quarter of 2020.
  • Net income (loss): Net income for the third quarter of 2021 was $0.9 million, or $0.09 per share, based on 9.8 million weighted average common shares outstanding. Net loss for the comparable 2020 period was $(0.9) million, or $(0.11) net loss per diluted share, based on 7.5 million weighted average common shares outstanding.
  • Adjusted net income (loss): Adjusted net loss for the third quarter of 2021 was $(1.3) million, or $(0.13) net loss per share compared to adjusted net loss for the third quarter of 2020 of $(0.9) million, or $(0.11) net loss per share.
  • EBITDA: EBITDA was $0.7 million for the third quarter of 2021, compared to an EBITDA loss of $(1.1) million for the third quarter of 2020.
  • Adjusted EBITDA loss: Adjusted EBITDA loss was $(1.2) million for the third quarter of 2021, compared to adjusted EBITDA loss of $(0.9) million for the third quarter of 2020.
  • Paid Terminals: Paid terminals in the market were 8,749 on September 30, 2021, compared to 3,813 on September 30, 2020, an increase of 129%.

2021 Third Quarter Conference Call and Webcast

TransAct is hosting a conference call and webcast today, November 9, 2021, beginning at 4:30 p.m. ET to discuss the Company’s preliminary third quarter 2021 results and other matters. Both the call and the webcast are open to the general public. The conference call number is 856-344-9290 and the conference ID number is 8161388 (domestic or international). Please call five minutes prior to the presentation to ensure that you are connected.

Interested parties may also access the conference call live on the Internet at www.transact-tech.com (select “Investor Relations” followed by “Events & Presentations”). Approximately two hours after the call has concluded, an archived version of the webcast will be available for replay at the same location.

Non-GAAP Financial Measures

TransAct is providing certain non-GAAP financial measures because the Company believes that these measures are helpful to investors and others in assessing the ongoing nature of what the Company’s management views as TransAct’s core operations. EBITDA and adjusted EBITDA provide the Company with an understanding of one aspect of earnings before the impact of investing and financing charges and income taxes. The Company believes that these non-GAAP financial measures provide relevant and useful information to an investor evaluating the Company’s operating performance because these measures are: (i) widely used by investors to measure a company’s operating performance without regard to items that do not reflect the ordinary earnings from operations excluded from the calculation of such measure; (ii) used as financial measurements by lenders and other parties to evaluate creditworthiness; and (iii) used by the Company’s management for various purposes including strategic planning and forecasting and assessing financial performance. Adjusted net income (loss) and adjusted net income (loss) per diluted share provide the Company with an understanding of the results of the primary operations of the business by excluding the effects of special items (for example, the forgiveness of the Company’s $2.2 million loan under the Paycheck Protection Program (the “PPP Loan”) administered by the Small Business Administration (the “SBA”) pursuant to the Coronavirus Aid, Relief, and Economic Security Act of 2020 (the “CARES Act”)) that do not reflect the ordinary earnings of the Company’s operations. The Company uses these measures to evaluate period-over-period operating performance because the Company believes this provides a more comparable measure of the Company’s continuing business, as these measures adjust for special items that are not reflective of the normal results of the business. These measures may be useful to an investor in evaluating the underlying operating performance of the Company’s business. The presentation of this non-GAAP information is not considered superior to or a substitute for, and should be read in conjunction with, the financial information prepared in accordance with GAAP.

EBITDA is defined as net income (loss) before net interest expense, income taxes, depreciation and amortization. A reconciliation of EBITDA to net income (loss), the most comparable GAAP financial measure, can be found attached to this release.

Adjusted EBITDA is defined as net income (loss) before net interest expense, income taxes, depreciation and amortization and is adjusted for share-based compensation and the impact of the forgiveness of the PPP Loan by the SBA pursuant to the CARES Act. The Company adjusts EBITDA for share-based compensation because the Company considers share-based compensation to be a non-cash expense similar to depreciation and amortization, and the Company adjusts for the impact of the PPP Loan forgiveness because the Company does not believe that this impact reflects ordinary earnings of the Company from operations. A reconciliation of adjusted EBITDA to net income (loss), the most comparable GAAP financial measure, can be found attached to this release.

Adjusted net income (loss) is defined as net income (loss) adjusted for the impact of the forgiveness of the PPP Loan by the SBA pursuant to the CARES Act. A reconciliation of adjusted net income (loss) to net income (loss), the most comparable GAAP financial measure, can be found attached to this release.

Adjusted net income (loss) per diluted share is defined as adjusted net income (loss) divided by diluted shares outstanding. A reconciliation of adjusted net income (loss) per diluted share to net income (loss) per diluted share, the most comparable GAAP financial measure, can be found attached to this release.

About TransAct Technologies Incorporated

TransAct Technologies Incorporated is a global leader in developing software-driven technology and printing solutions for high-growth markets including food service, casino and gaming, POS automation, and oil and gas. The Company’s solutions are designed from the ground up based on customer requirements and are sold under the BOHA! ™, AccuDate™, EPICENTRAL®, Epic, Ithaca® and Printrex® brands. TransAct has sold over 3.6 million printers, terminals and other hardware devices around the world and is committed to providing world-class service, spare parts and accessories to support its installed product base. Through the TransAct Services Group, the Company also provides customers with a complete range of supplies and consumable items both online at http://www.transactsupplies.com and through its direct sales team. TransAct is headquartered in Hamden, CT. For more information, please visit http://www.transact-tech.com or call (203) 859-6800.

TransAct®, BOHA!™, AccuDate™, Epic, EPICENTRAL®, Ithaca® and Printrex® are trademarks of TransAct Technologies Incorporated. ©2021 TRANSACT Technologies Incorporated. All rights reserved.

Cautionary Statement Regarding Preliminary Financial Information

The Company has prepared the preliminary financial information set forth below on a materially consistent basis with its historical financial information and in good faith based upon its internal reporting as of and for the three and nine months ended September 30, 2021. This financial information is preliminary and is thus inherently uncertain and subject to change as the Company finalizes its financial results and related review for the three and nine months ended September 30, 2021. During the course of the preparation of the Company’s consolidated financial statements and related notes as of and for the three and nine months ended September 30, 2021, the Company may identify items that could cause its final reported results to be materially different from the preliminary financial information set forth above. As a result, there can be no assurance that the Company’s final results for this period will not differ from the preliminary financial information.

This preliminary financial information should not be viewed as a substitute for full financial statements prepared in accordance with GAAP. In addition, this preliminary financial information is not necessarily indicative of the results to be achieved for any future period.

Forward-Looking Statements

Certain statements in this press release include forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology, such as "may", "will", "expect", "intend", "estimate", "anticipate", "believe", or "continue", or the negative thereof, or other similar words. All forward-looking statements involve risks and uncertainties, including, but not limited to, the adverse effects of the COVID-19 pandemic, related vaccination rates and the emergence of virus variants on our business, operations, financial condition, results of operations and capital resources, including as a result of supply chain disruptions, shutdowns and/or operational restrictions imposed on our customers, an inability of our customers to make payments on time or at all, diversion of management attention, necessary modifications to our business practices and operations, cost cutting measures we have made and may continue to make, a possible future reduction in the value of goodwill or other intangible assets, inadequate manufacturing capacity or a shortfall or excess of inventory as a result of difficulty in predicting manufacturing requirements due to volatile economic conditions, price increases or decreased availability of component parts or raw materials, exchange rate fluctuations, volatility of and decreases in trading prices of our common stock and the availability of needed financing on acceptable terms or at all; our ability to successfully develop new products that garner customer acceptance and generate sales, both domestically and internationally, in the face of substantial competition; our reliance on an unrelated third party to develop, maintain and host certain web-based food service application software and develop and maintain selected components of our downloadable software applications pursuant to a non-exclusive license agreement, and the risk that interruptions in our relationship with that third party could materially impair our ability to provide services to our food service technology customers on a timely basis or at all and could require substantial expenditures to find or develop alternative software products; our ability to successfully transition our business into the food service technology market; our ability to fully remediate a previously disclosed material weakness over internal control over financial reporting; risks associated with potential future acquisitions; general economic conditions; our dependence on contract manufacturers for the assembly of a large portion of our products in Asia; our dependence on significant suppliers; our ability to recruit and retain quality employees as the Company grows; our dependence on third parties for sales outside the United States; our dependence on technology licenses from third parties; marketplace acceptance of new products; risks associated with foreign operations; the availability of third-party components at reasonable prices; price wars or other significant pricing pressures affecting the Company's products in the United States or abroad; increased product costs or reduced customer demand for our products due to changes in U.S. policy that may result in trade wars or tariffs; our ability to protect intellectual property; the effect of the United Kingdom’s withdrawal from the European Union; and other risk factors detailed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, and other reports filed with the Securities and Exchange Commission. Actual results may differ materially from those discussed in, or implied by, the forward-looking statements. The forward-looking statements speak only as of the date of this release, and the Company assumes no duty to update them to reflect new, changing or unanticipated events or circumstances, except as required by applicable law.

- Financial tables follow –

TRANSACT TECHNOLOGIES INCORPORATED

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Preliminary and Unaudited)

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

September 30,

 

September 30,

 

 

2021

 

2020

 

2021

 

2020

 

 

(In thousands, except per share data)

 

 

 

 

 

 

 

 

 

Net sales

 

$10,637

 

$7,300

 

$28,263

 

$22,832

Cost of sales

 

6,320

 

3,951

 

17,432

 

12,275

Gross profit

 

4,317

 

3,349

 

10,831

 

10,557

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

Engineering, design and product development

 

1,876

 

1,445

 

5,483

 

4,197

Selling and marketing

 

1,899

 

1,258

 

5,109

 

4,885

General and administrative

 

2,146

 

2,125

 

7,264

 

6,987

 

 

5,921

 

4,828

 

17,856

 

16,069

Operating loss

 

(1,604)

 

(1,479)

 

(7,025)

 

(5,512)

 

 

 

 

 

 

 

 

 

Interest and other income (expense):

 

 

 

 

 

 

 

 

Interest, net

 

(29)

 

(19)

 

(71)

 

(41)

Other, net

 

2,104

 

116

 

2,004

 

(60)

 

 

2,075

 

97

 

1,933

 

(101)

 

 

 

 

 

 

 

 

 

Income (loss) before income taxes

 

471

 

(1,382)

 

(5,092)

 

(5,613)

Income tax benefit

 

439

 

515

 

1,682

 

1,901

Net income (loss)

 

$910

 

$(867)

 

$(3,410)

 

$(3,712)

 

 

 

 

 

 

 

 

 

Net income (loss) per common share:

 

 

 

 

 

 

 

 

Basic

 

$0.10

 

$(0.11)

 

$(0.37)

 

$(0.49)

Diluted

 

$0.09

 

$(0.11)

 

$(0.37)

 

$(0.49)

 

 

 

 

 

 

 

 

 

Shares used in per share calculation:

 

 

 

 

 

 

 

 

Basic

 

9,408

 

7,548

 

9,112

 

7,533

Diluted

 

9,846

 

7,548

 

9,112

 

7,533

 

 

 

 

 

 

 

 

 

SUPPLEMENTAL INFORMATION – SALES BY MARKET:

(Preliminary and Unaudited)

 

Three months ended

 

Nine months ended

 

September 30,

 

September 30,

 

2021

2020

 

2021

2020

 

(In thousands)

 

 

 

 

 

 

Food service technology

$3,282

$2,349

 

$9,103

$4,924

POS automation

1,188

742

 

3,608

2,781

Casino and gaming

4,036

2,009

 

10,368

8,300

Lottery

-

-

 

-

817

Printrex

160

107

 

431

232

TransAct Services Group

1,971

2,093

 

4,753

5,778

Total net sales

$10,637

$7,300

 

$28,263

$22,832

TRANSACT TECHNOLOGIES INCORPORATED

CONDENSED CONSOLIDATED BALANCE SHEETS

(Preliminary and Unaudited)

 

 

 

 

 

 

 

September 30,

 

December 31,

 

 

2021

 

2020

 

 

(In thousands)

Assets:

 

 

 

 

Current assets:

 

 

 

 

Cash and cash equivalents

 

$18,658

 

$10,359

Accounts receivable, net

 

6,501

 

3,377

Note receivable

 

-

 

100

Inventories

 

6,369

 

11,286

Prepaid income taxes

 

2,519

 

2,409

Other current assets

 

1,182

 

644

Total current assets

 

35,229

 

28,175

 

 

 

 

 

Fixed assets, net

 

2,332

 

1,950

Note receivable, net of current portion

 

-

 

1,584

Right-of-use asset

 

2,750

 

3,618

Goodwill

 

2,621

 

2,621

Deferred tax assets

 

4,506

 

2,939

Intangible assets, net

 

435

 

583

Other assets

 

476

 

777

 

 

13,120

 

14,072

Total assets

 

$48,349

 

$42,247

 

 

 

 

 

Liabilities and Shareholders’ Equity:

 

 

 

 

Current liabilities:

 

 

 

 

Accounts payable

 

$1,676

 

$1,691

Accrued liabilities

 

3,511

 

3,665

Lease liability

 

816

 

837

Deferred revenue

 

768

 

504

Total current liabilities

 

6,771

 

6,697

 

 

 

 

 

Long-term debt

 

-

 

2,173

Deferred revenue, net of current portion

 

207

 

111

Lease liability, net of current portion

 

1,956

 

2,864

Other liabilities

 

135

 

166

 

 

2,298

 

5,314

Total liabilities

 

9,069

 

12,011

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

Common stock

 

139

 

130

Additional paid-in capital

 

54,873

 

42,536

Retained earnings

 

16,308

 

19,718

Accumulated other comprehensive income (loss), net of tax

 

70

 

(38)

Treasury stock, at cost

 

(32,110)

 

(32,110)

Total shareholders’ equity

 

39,280

 

30,236

Total liabilities and shareholders’ equity

 

$48,349

 

$42,247

 

 

 

 

TRANSACT TECHNOLOGIES INCORPORATED

RECONCILIATION OF GAAP EARNINGS FINANCIAL MEASURES TO CORRESPONDING

NON-GAAP FINANCIAL MEASURES

(Preliminary and Unaudited, thousands of dollars, except percentages and per share amounts)

 

 

Three months ended

September 30, 2021

 

 

 

 Reported

 

Adjustments(1)

 

Adjusted

Non-GAAP

Operating expenses

 

$5,921

 

$-

 

$5,921

% of net sales

 

55.7%

 

 

 

55.7%

 

 

 

 

 

 

 

Operating loss

 

(1,604)

 

-

 

(1,604)

% of net sales

 

(15.1)%

 

 

 

(15.1)%

 

 

 

 

 

 

 

Interest and other income (expense)

 

2,075

 

(2,173)

 

(98)

Income (loss) before income taxes

 

471

 

(2,173)

 

(1,702)

Income tax benefit

 

439

 

-

 

439

Net income (loss)

 

910

 

(2,173)

 

(1,263)

Net income (loss) per common share:

 

 

 

 

 

 

Basic

 

$0.10

 

$(0.23)

 

$(0.13)

Diluted

 

$0.09

 

$(0.22)

 

$(0.13)

1. Adjustment includes $2,173 gain on forgiveness of the PPP Loan that occurred in July 2021.

 

 

Three months ended

September 30, 2020

 

 

 

Reported

 

 Adjustments(2)

 

Adjusted

Non-GAAP

Operating expenses

 

$4,828

 

$-

 

$4,828

% of net sales

 

66.1%

 

 

 

66.1%

 

 

 

 

 

 

 

Operating loss

 

(1,479)

 

-

 

(1,479)

% of net sales

 

(20.3)%

 

 

 

(20.3)%

 

 

 

 

 

 

 

Interest and other income

 

97

 

-

 

97

Loss before income taxes

 

(1,382)

 

-

 

(1,382)

Income tax benefit

 

515

 

-

 

515

Net loss

 

(867)

 

-

 

(867)

Net loss per common share:

 

 

 

 

 

 

Basic

 

$(0.11)

 

-

 

$(0.11)

Diluted

 

$(0.11)

 

-

 

$(0.11)

2. No adjustments. 

TRANSACT TECHNOLOGIES INCORPORATED

RECONCILIATION OF GAAP EARNINGS FINANCIAL MEASURES TO CORRESPONDING

NON-GAAP FINANCIAL MEASURES

(Preliminary and Unaudited, thousands of dollars, except percentages and per share amounts)

 

 

Nine months ended

September 30, 2021

 

 

 

Reported

 

 Adjustments(3)

 

Adjusted

Non-GAAP

Operating expenses

 

$17,856

 

$-

 

$17,856

% of net sales

 

63.2%

 

 

 

63.2%

 

 

 

 

 

 

 

Operating loss

 

(7,025)

 

-

 

(7,025)

% of net sales

 

(24.9)%

 

 

 

(24.9)%

 

 

 

 

 

 

 

Interest and other income (expense)

 

1,933

 

(2,173)

 

(240)

Loss before income taxes

 

(5,092)

 

(2,173)

 

(7,265)

Income tax benefit

 

1,682

 

-

 

1,682

Net loss

 

(3,410)

 

(2,173)

 

(5,583)

Net loss per common share:

 

 

 

 

 

 

Basic

 

$(0.37)

 

$(0.24)

 

$(0.61)

Diluted

 

$(0.37)

 

$(0.24)

 

$(0.61)

3. Adjustment includes $2,173 gain on forgiveness of the PPP Loan that occurred in July 2021.

 

 

Nine months ended

September 30, 2020

 

 

 

 Reported

 

 Adjustments(4)

 

Adjusted

Non-GAAP

Operating expenses

 

$16,069

 

$-

 

$16,069

% of net sales

 

70.4%

 

 

 

70.4%

 

 

 

 

 

 

 

Operating loss

 

(5,512)

 

-

 

(5,512)

% of net sales

 

(24.1)%

 

 

 

(24.1)%

 

 

 

 

 

 

 

Interest and other expense

 

(101)

 

-

 

(101)

Loss before income taxes

 

(5,613)

 

-

 

(5,613)

Income tax benefit

 

1,901

 

-

 

1,901

Net loss

 

(3,712)

 

-

 

(3,712)

Net loss per common share:

 

 

 

 

 

 

Basic

 

$(0.49)

 

-

 

$(0.49)

Diluted

 

$(0.49)

 

-

 

$(0.49)

4. No adjustments.

TRANSACT TECHNOLOGIES INCORPORATED

RECONCILIATION OF NET INCOME (LOSS) TO EBITDA AND ADJUSTED EBITDA

NON-GAAP FINANCIAL MEASURES

(Preliminary and Unaudited)

 

 

Three Months Ended

 

Nine Months Ended

 

 

September 30,

 

September 30,

 

 

2021

 

2020

 

2021

 

2020

 

 

(In thousands)

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$910

 

$(867)

 

$(3,410)

 

$(3,712)

 

 

 

 

 

 

 

 

 

Interest expense, net

 

29

 

19

 

71

 

41

Income tax benefit

 

(439)

 

(515)

 

(1,682)

 

(1,901)

Depreciation and amortization

 

235

 

263

 

721

 

758

 

 

 

 

 

 

 

 

 

EBITDA

 

735

 

(1,100)

 

(4,300)

 

(4,814)

 

 

 

 

 

 

 

 

 

Share-based compensation expense

 

257

 

231

 

952

 

644

Forgiveness of the PPP Loan

 

(2,173)

 

-

 

(2,173)

 

-

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

 

$(1,181)

 

$(869)

 

$(5,521)

 

$(4,170)

 

 

 

 

 

 

 

 

 

 

Contacts

Bart Shuldman

Chairman and Chief Executive Officer

TransAct Technologies Incorporated

Ryan Gardella

ICR, Inc.

Ryan.Gardella@icrinc.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.